News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Bio-Surfaces, Inc. Receives Award for OrthoGlide(TM) Medial Knee Implant


4/11/2007 11:17:13 AM

MINNEAPOLIS, April 11 /PRNewswire/ -- Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer, announced today the OrthoGlide Medial Knee Implant is the recipient of a 2007 Medical Design and Excellence Award (MDEA) in the Implant and Tissue-Replacement Products category.

"Advanced Bio-Surfaces is honored to be recognized by MDEA for the OrthoGlide implant. The product's superior engineering and innovative design results in fixation of the implant to the tibial plateau without the use of cement or screws and thus offers a minimally invasive choice for the treatment of medial compartment osteoarthritis of the knee," said Dr. Jeff Felt, Chairman and CEO of Advanced Bio-Surfaces. "ABS is proud of our engineering team's accomplishment in designing and developing a product that will be recognized along side many prestigious past MDEA winners."

About Medical Design Excellence Awards

The Medical Design Excellence Awards is the only exclusive program that recognizes contributions and advances in the design of medical products. Entries are evaluated on the basis of their design and engineering features and are reviewed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomechanical engineering, human factors, industrial design, medicines and diagnostics.

The 2007 MDEA winners will be honored at a ceremony during the Medical Design and Manufacturing (MD&M) East Conference on June 13th, 2007 at the Jacob K. Javits Convention Center in New York City.

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of minimally- invasive and innovative joint repair devices. The company's first commercialized product, the OrthoGlide, is an interpositional arthroplasty for the medial compartment of the knee in patients with moderate to severe osteoarthritis. The company received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) and CE mark notification from its Notified Body, TUV Product Services (Munich) in February 2006. For additional information contact Robert Siegfried at 952.912.5400.

Advanced Bio-Surfaces, Inc.

CONTACT: Robert Siegfried, VP, Finance and Administration of AdvancedBio-Surfaces, Inc., +1-952-912-5400


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES